Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Aichi Gakuin University.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Keiko Naruse, Aichi Gakuin University
First received: March 5, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted
The purpose of this study is to evaluate the effects of Sarpogrelate in endothelial progenitor cells of patients with atherosclerosis.
||Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
||Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells
Primary Outcome Measures:
- The number and function of endothelial progenitor cells [ Time Frame: 3 months ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||October 2012 (Final data collection date for primary outcome measure)
Endothelial progenitor cells play an important role in vasculogenesis and vascular repair. Sarpogrelate, a inhibitor of HT2A, is used an an anti-platelet drug, however, a direct effect in vascular cells is supposed.
|Ages Eligible for Study:
||20 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Patients with atherosclerosis
- Patients with high risk of bleeding
- Patients with pregnancy
- Patients with allergic reaction of Salpogrelate
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01548274
|Nagoya, Aichi, Japan, 464-8651 |
|Contact: Keiko Naruse, M.D., Ph.D. +81-52-759-2111 ext 5369 email@example.com |
Aichi Gakuin University
No publications provided
||Keiko Naruse, Associate professor, Aichi Gakuin University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||March 5, 2012
||March 5, 2012
||Japan: Ministry of Health, Labor and Welfare
Keywords provided by Aichi Gakuin University:
endothelial progenitor cells
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 25, 2015
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Platelet Aggregation Inhibitors